Cationic phospholipids for transfection
US5891714A · kind A · utility
11Cited by
11References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1995 |
| Grant date | Apr 6, 1999 |
| Priority date | — |
| Expiry date | Jun 6, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65324
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cationic phospholipids and their use in treating pathogen-associated disease are disclosed. The class of phospholipids comprises the phosphotriester derivatives of phosphoglycerides and sphingolipids. Liposomes comprising one or more of the cationic phospholipids are effective in the lipofection of nuclidic acids and are therefore useful in methods of treating disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.